Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures

Part of paid clinical trials in Wilmington, Delaware.

Sponsor
NeuraLight
Study ID
NCT05476523
Status
Recruiting

Conditions

  • Eye Movement

Eligibility Criteria

Sex
ALL
Age
18 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • NeuraLight — OTHER
    NeuraLight is an investigational software-based platform used for measuring eye movements in response to visual stimuli and captured using a simple webcam

Study Details

This is an observational prospective study in a cohort of healthy subjects who are enrolled using convenience and snowballing sampling. The aims of the study is to demonstrate the efficacy of using NeuraLight system to capture oculometric data from healthy participants and to validate the data capture of NeuraLight oculometric measurements as compared with a validated eye-tracker system in subjects who meet the inclusion criteria and who provide a signed Informed Consent.

Key Dates

Start date
Jul 22, 2022
Status verified
May 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
2,000 participants (estimated)

Arms

  • Arm: Healthy Data Collection
    As a part of the study, a group of up to 2000 healthy subjects will undergo a NeuraLight session including oculometric measurements and eye-tracking recordings using a novel software-based platform and an eye-tracking system (approx. 15 minutes). The oculometric evaluation will occur for every patient 1 time, and all subjects will be recruited over a period of 36 months. All assessments will be performed during a clinic visit unless authorized to be conducted remotely

Primary Outcome Measure

Efficacy of data capture [ Time Frame: 36 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
NeuraLightWilmingtonDelaware19801
Eitan Raveh, PhD

Find similar trials in Wilmington, DE